Meccellis Biotech is a French manufacturer of biologic implants founded in 2011. The company specializes in Tissue and Cell Engineering and offers a diverse range of products for various surgical specialties. With 7 years of marketing efforts, Meccellis Biotech has expanded its presence to 25 countries, solidifying its position as a key player in the manufacturing of biomaterials. The recent $1.50M grant investment received on 29 November 2022 from the European Innovation Council further validates the company's potential for growth and innovation in the Biopharma and Biotechnology industries. For more information on their biologic implants, interested parties can contact Meccellis Biotech at [email protected] or on phone at +33 (0) 5 17 81 07 63. The company's relentless commitment to excellence and expertise positions it as a reference in the field.
No recent news or press coverage available for Meccellis Biotech.